Skip to main content
Premium Trial:

Request an Annual Quote

OGT Licenses Tridend Tech to UK Biotech MassTag

NEW YORK (GenomeWeb News) — Oxford Gene Technology today said it has granted UK biotech MassTag Technologies licensing rights to its Tridend technology.
 
The company said the option on the license will become exclusive when MassTag completes a fund-raising campaign. Also through the agreement, OGT will become a minority shareholder in MassTag.
 
The technology was developed under former OGT subsidiary Tridend and is suited for mass spec systems because it offers multiplexing and ability to analyze multiple samples, according to OGT.
 
OGT CEO Mike Evans said the agreement came after a strategic review, when OGT began focusing on finding partnerships in the microarray field.
 
Financial terms of the agreement were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.